Fabrication of quercetin nanocrystals: Comparison of different methods

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 80, Issue 1, 2012, Pages 113-121

  Kakran, Mitali ^a   Shegokar, Ranjita ^b   Sahoo, Nanda Gopal ^a   Al Shaal, Loaye ^b   Li, Lin ^a   Müller, Rainer H ^b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Bead mill; Cavi precipitation; High pressure homogenization; Nanosuspension; Quercetin; Saturation solubility

Indexed keywords

NANOCRYSTAL; QUERCETIN;

ARTICLE; BEAD MILL; CAVI PRECIPITATION; COMPARATIVE STUDY; CRYSTAL STRUCTURE; FLOW RATE; HIGH PRESSURE HOMOGENIZATION; KINETICS; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PRECIPITATION; X RAY DIFFRACTION; ZETA POTENTIAL;

CHEMICAL PRECIPITATION; DRUG COMPOUNDING; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; QUERCETIN; SOLUBILITY; SUSPENSIONS; X-RAY DIFFRACTION;

EID: 83955162904     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.08.006     Document Type: Article

References (25)

1. R.H.H. Neubert Potentials of new nanocarriers for dermal and transdermal drug delivery Eur. J. Pharm. Biopharm. 77 2011 1 2
2. A.M. Cerdeira, M. Mazzotti, and B. Gander Miconazole nanosuspensions: influence of formulation variables on particle size reduction and physical stability Int. J. Pharm. 396 2010 210 218
3. A.O.K. Hassan, and A.H. Elshafeey Nanosized particulate systems for dermal and transdermal delivery J. Biomed. Nanotechnol. 6 2010 621 633
4. A. Schroeter, T. Engelbrecht, R.H.H. Neubert, and A.S.B. Goebel New nanosized technologies for dermal and transdermal drug delivery. A review J. Biomed. Nanotechnol. 6 2010 511 528
5. M.A. Kassem, A.A.A. Rahman, M.M. Ghorab, M.B. Ahmed, and R.M. Khalil Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs Int. J. Pharm. 340 2007 126 133 (Pubitemid 47043351)
6. W.H. Roa, S. Azarmi, M.H.D.K. Al-Hallak, W.H. Finlay, A.M. Magliocco, and R. Löbenberg Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model J. Control. Release 150 2011 49 55
7. R.B. Gupta Fundamentals of drug nanoparticles R.B. Gupta, U.B. Kompella, Nanoparticle Technology for Drug Delivery 2006 Taylor & Francis New York 3 4
8. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 1995 413 420
9. C.M. Keck, and R.H. Müller Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization Eur. J. Pharm. Biopharm. 62 2006 3 16 (Pubitemid 41736019)
10. G.G. Liversidge, K.C. Cundy, J.F. Bishop, D.A. Czekai, US Patent 145,684, 1992.
11. R.H. Müller, J. Moschwitzer, Method and device for producing very fine particles and coating such particles, Patent PCT/EP2006/009930, 2006.
12. A.W. Boots, G.R. Haenen, and A. Bast Health effects of quercetin: from antioxidant to nutraceutical Eur. J. Pharmacol. 585 2008 325 337
13. M.M. Chan, D. Fong, K.J. Soprano, W.F. Holmes, and H. Heverling Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents J. Cell. Physiol. 194 2003 63 70 (Pubitemid 35424228)
14. K.A. Khaled, Y.M. El-Sayed, and B.M. Al-Hadiya Disposition of the flavonoid quercetin in rats after single intravenous and oral doses Drug Dev. Ind. Pharm. 29 2003 397 403 (Pubitemid 36528607)
15. V.A. Bhattaram, U. Graefe, C. Kohlert, M. Veit, and H. Derendorf Pharmacokinetics and bioavailability of herbal medicinal products Phytomedicine 9 2002 1 33 (Pubitemid 41623448)
16. M. Kakran, R. Shegokar, L. Al Shaal, N.G. Sahoo, L. Li, R.H. Müller, Production Optimization of Antioxidant Quercetin Nanocrystals, Abstract 2265, AAPS Annual Meeting and Exposition, October 23-27, 2011, Washington, DC, USA.
17. K. Krause, and R.H. Müller Production and characterisation of highly concentrated nanosuspensions by high pressure homogenization Int. J. Pharm. 214 2001 21 24 (Pubitemid 32244072)
18. P. Ader, A. Wessmann, and S. Wolffram Bioavailability and metabolism of the flavonol quercetin in the pig Free Radic. Biol. Med. 28 2000 1056 1067 (Pubitemid 30314704)
19. R.M. Mainardes, and R.C. Evangelista PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution Int. J. Pharm. 290 2005 137 144 (Pubitemid 40139053)
20. D.S. Kohane, J.Y. Tse, Y. Yeo, R. Padera, M. Shubina, and L. Robert Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum J. Biomed. Mater. Res. Part A 77A 2006 351 361 (Pubitemid 47233537)
21. M. Kakran, N.G. Sahoo, L. Li, Z. Judeh, Y. Wang, K. Chong, and L. Loh Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension Int. J. Pharm. 383 2010 285 292
22. M. Thommes, D.R. Ely, M.T. Carvajal, and R. Pinal Improvement of the dissolution rate of poorly soluble drugs by solid crystal suspensions Mol. Pharm. 8 2011 727 735
23. R. Mauludin, R.H. Müller, and C.M. Keck Kinetic solubility and dissolution velocity of rutin nanocrystals Eur. J. Pharm. Sci. 36 2009 502 510
24. A.A. Noyes, and W.R. Whitney The rate of solution of solid substances in their own solutions J. Am. Chem. Soc. 19 1897 930 934
25. R.H. Müller, and A. Akkar Drug nanocrystals of poorly soluble drugs H.S. Nalwa, Encyclopedia of Nanoscience and Nanotechnology 2004 American Scientific Publishers 627 638